These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes. Guney C; Akar F J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315 [TBL] [Abstract][Full Text] [Related]
26. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2. Hudák A; Letoha A; Szilák L; Letoha T Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069441 [TBL] [Abstract][Full Text] [Related]
27. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2. Verkhivker G Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276 [TBL] [Abstract][Full Text] [Related]
29. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Huo J; Zhao Y; Ren J; Zhou D; Duyvesteyn HME; Ginn HM; Carrique L; Malinauskas T; Ruza RR; Shah PNM; Tan TK; Rijal P; Coombes N; Bewley KR; Tree JA; Radecke J; Paterson NG; Supasa P; Mongkolsapaya J; Screaton GR; Carroll M; Townsend A; Fry EE; Owens RJ; Stuart DI Cell Host Microbe; 2020 Sep; 28(3):445-454.e6. PubMed ID: 32585135 [TBL] [Abstract][Full Text] [Related]
30. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815 [TBL] [Abstract][Full Text] [Related]
31. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling. Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526 [TBL] [Abstract][Full Text] [Related]
32. How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17. Healy EF Biochem Biophys Res Commun; 2022 Feb; 593():52-56. PubMed ID: 35063769 [TBL] [Abstract][Full Text] [Related]
33. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Huo J; Le Bas A; Ruza RR; Duyvesteyn HME; Mikolajek H; Malinauskas T; Tan TK; Rijal P; Dumoux M; Ward PN; Ren J; Zhou D; Harrison PJ; Weckener M; Clare DK; Vogirala VK; Radecke J; Moynié L; Zhao Y; Gilbert-Jaramillo J; Knight ML; Tree JA; Buttigieg KR; Coombes N; Elmore MJ; Carroll MW; Carrique L; Shah PNM; James W; Townsend AR; Stuart DI; Owens RJ; Naismith JH Nat Struct Mol Biol; 2020 Sep; 27(9):846-854. PubMed ID: 32661423 [TBL] [Abstract][Full Text] [Related]
34. HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State. Domovitz T; Ayoub S; Werbner M; Alter J; Izhaki Tavor L; Yahalom-Ronen Y; Tikhonov E; Meirson T; Maman Y; Paran N; Israely T; Dessau M; Gal-Tanamy M Microbiol Spectr; 2022 Dec; 10(6):e0115022. PubMed ID: 36314945 [TBL] [Abstract][Full Text] [Related]
36. Population-Specific Hashizume M; Gonzalez G; Ono C; Takashima A; Iwasaki M Viruses; 2021 Jan; 13(1):. PubMed ID: 33418950 [TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Datta PK; Liu F; Fischer T; Rappaport J; Qin X Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005 [TBL] [Abstract][Full Text] [Related]
38. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites. Qiao B; Olvera de la Cruz M ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067 [TBL] [Abstract][Full Text] [Related]
39. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19. Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S J Genet; 2021; 100(1):. PubMed ID: 33707363 [TBL] [Abstract][Full Text] [Related]
40. Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites. Williams TL; Strachan G; Macrae RGC; Kuc RE; Nyimanu D; Paterson AL; Sinha S; Maguire JJ; Davenport AP Sci Rep; 2021 Dec; 11(1):24336. PubMed ID: 34934117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]